Antipsychotic Medication Use in Children and Adolescents: What's a parent to do?

2009 ◽  
Author(s):  
Lloyd I. Sederer
Keyword(s):  
Children And Adolescents ◽  
Antipsychotic Medication ◽  
Medication Use

scholarly journals Antipsychotic Medication use Measures for children and adolescents: Metabolic Screening for children on antipsychotics

2015 ◽  
Vol 18 (3) ◽  
pp. A275
Author(s):  
III B. Banahan ◽  
S. Nunna ◽  
R. Shah ◽  
S.P. Harwick ◽  
J.P. Clark
Keyword(s):  
Children And Adolescents ◽  
Antipsychotic Medication ◽  
Medication Use ◽  
Metabolic Screening

Factors associated with physician consultation and medication use in children and adolescents with chronic pain: A scoping review and original data

2020 ◽  
Vol 25 (1) ◽  
pp. 88-106
Author(s):  
Anna Könning ◽  
Nicola Rosenthal ◽  
Michelle Friese ◽  
Gerrit Hirschfeld ◽  
Donnamay Brown ◽  
...  
Keyword(s):  
Chronic Pain ◽  
Children And Adolescents ◽  
Scoping Review ◽  
Medication Use ◽  
Original Data ◽  
Factors Associated ◽  
Physician Consultation

scholarly journals A retrospective, longitudinal study of factors associated with new antipsychotic medication use among recently admitted long-term care residents

2015 ◽  
Vol 15 (1) ◽  
Author(s):  
Andrea Foebel ◽  
Anna Ballokova ◽  
Nathalie IH Wellens ◽  
Daniela Fialova ◽  
Koen Milisen ◽  
...  
Keyword(s):  
Longitudinal Study ◽  
Antipsychotic Medication ◽  
Long Term Care ◽  
Medication Use ◽  
Term Care ◽  
Factors Associated

scholarly journals FACTORS THAT INFLUENCE PSYCHOTROPIC MEDICATION USE

2019 ◽  
Vol 3 (Supplement_1) ◽  
pp. S558-S558
Author(s):  
Barbara Resnick ◽  
Elizabeth Galik
Keyword(s):  
Cognitive Impairment ◽  
Data Analysis ◽  
Antipsychotic Medication ◽  
Psychotropic Medication ◽  
Medication Use ◽  
Secondary Data ◽  
Behavioral Symptoms ◽  
Factors Associated ◽  
Resistiveness To Care ◽  
N 93

Abstract Understanding the factors that influence psychotropic can guide reduction in use of these medications. This study described predictors of psychotropics use among residents with moderate to severe cognitive impairment. This was a secondary data analysis using baseline data from the first 341 residents in the EIT-4-BPSD trial. Predictive measures included demographics, agitation, resistiveness to care, depression, cognition, pain, facility factors and state. Overall 63% (n=211) received at least one psychotropic medication, 16% (n=52) an anti-seizure medication, 23% (n=77) an anxiolytic, 30% (n=99) an antidepressant, 2% (n=8) a sedative hypnotic, 28% (n=93) an antipsychotic medication, and 9% (n=29) an opioid. Model testing explained 9 to 15% of psychotropic medication use. There were high rates of psychotropic medication use and a limited association between demographic factors, behavioral symptoms, and psychotropic medication use. Continued research is needed to explore additional factors associated with psychotropic medication use such as beliefs of providers.

Sign in / Sign up

Export Citation Format

Share Document